MURFREESBORO, TN / ACCESSWIRE / November 5, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that after more than 30 years of leadership, W. Andrew "Andy" Adams has notified the Board ...

MURFREESBORO, TN / ACCESSWIRE / November 5, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its fourth quarter dividend of $0.90 per common share on January 29, 2025 ...

CALGARY, AB / ACCESSWIRE / November 5, 2024 / CannaPharmaRX, Inc. (OTC PINK:CPMD), a future leader in cutting-edge, highly efficient cannabis production, is pleased to announce continued progress at ...

LEWES, DE / ACCESSWIRE / November 5, 2024 / Beebe Healthcare has partnered with Sublimation Health to transform its digital landscape with an Epic Electronic Health Record (EHR) system hosted on ...

Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized neoantigen cancer immunotherapies, announces further promising data from the fully enrolled Phase 1b/2 study ...

Predicated on an unrivaled trove of millions of data points amassed over 20 years, these AI tools accurately predict near-term risk of ED, all-cause hospitalization, or death sans mitigation.NEW YORK, ...

Tessellate BIO, a preclinical stage biotechnology company with a focus on novel Synthetic Lethality approaches, today announces the appointment of Dr. Lara Boyd as Chief Business Officer.

Brings over 30 years of experience in cardiovascular clinical research, business development, training, education, and medical affairs Strengthens Xeltis’ leadership team following IDE approval for ...

Award Recognizes Vheda Health's Commitment to Excellence in Transforming Health Outcomes for Centene's Underserved PopulationsCOLUMBIA, MD. / ACCESSWIRE / November 5, 2024 / Vheda Health, a leader in ...

SALT LAKE CITY, UT / ACCESSWIRE / November 5, 2024 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Carrie Leigh to its Board of Directors. Ms. Leigh, ...

Seaport Therapeutics (“Seaport or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the ...

PersonnelPharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as Chief Executive Officer 05-Nov-2024 / 10:02 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the ...